SER-252 — Topline data
H1 2027
Serina expects to report topline data from the single-ascending-dose portion of the study in the first half of 2027.Source filing
SER biotech catalysts & pipeline
SERINA THERAPEUTICS INC · Data as of 2026-10-25
catalyst calendar
/